Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) EPS (Basic): 2021-2025

Historic EPS (Basic) for Krystal Biotech (KRYS) over the last 5 years, with Sep 2025 value amounting to $2.74.

  • Krystal Biotech's EPS (Basic) rose 188.42% to $2.74 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.90, marking a year-over-year increase of 275.00%. This contributed to the annual value of $3.12 for FY2024, which is 680.00% up from last year.
  • According to the latest figures from Q3 2025, Krystal Biotech's EPS (Basic) is $2.74, which was up 106.02% from $1.33 recorded in Q2 2025.
  • Krystal Biotech's EPS (Basic)'s 5-year high stood at $2.88 during Q3 2023, with a 5-year trough of -$1.99 in Q1 2022.
  • For the 3-year period, Krystal Biotech's EPS (Basic) averaged around $0.78, with its median value being $0.95 (2024).
  • As far as peak fluctuations go, Krystal Biotech's EPS (Basic) plummeted by 168.92% in 2022, and later surged by 4,033.33% in 2025.
  • Quarterly analysis of 5 years shows Krystal Biotech's EPS (Basic) stood at -$0.95 in 2021, then plummeted by 31.58% to -$1.25 in 2022, then surged by 125.60% to $0.32 in 2023, then spiked by 396.88% to $1.59 in 2024, then spiked by 188.42% to $2.74 in 2025.
  • Its EPS (Basic) was $2.74 in Q3 2025, compared to $1.33 in Q2 2025 and $1.24 in Q1 2025.